Detailed answers about TIMOLEON THERAPEUTICS LTD, including incorporation, status, business activity, and accounts information.
When was TIMOLEON THERAPEUTICS LTD founded?
TIMOLEON THERAPEUTICS LTD was officially incorporated on 3 March 2026 and is registered under company number 17067450. Incorporation establishes the company as a legal entity registered at Companies House, allowing it to trade, enter contracts, and operate under UK company law.
What type of company is TIMOLEON THERAPEUTICS LTD?
Private Limited Company. This classification indicates the legal structure of the company, which determines the way it is governed, its liability, and regulatory obligations. A private limited company (Ltd) limits the personal liability of its shareholders.
What is the current status of TIMOLEON THERAPEUTICS LTD?
TIMOLEON THERAPEUTICS LTD's current status is Active. The company status indicates whether it is actively trading, dormant, or has been dissolved. Maintaining an active status is essential for legally conducting business, filing accounts, and maintaining credibility with partners and lenders.
What does TIMOLEON THERAPEUTICS LTD do?
TIMOLEON THERAPEUTICS LTD operates in the following sectors: 62012 - Business and domestic software development, 63110 - Data processing, hosting and related activities, 72110 - Research and experimental development on biotechnology, 72190 - Other research and experimental development on natural sciences and engineering. These SIC codes provide insight into the company's business activities and industry focus.
What is TIMOLEON THERAPEUTICS LTD's registered address?
The registered office address of TIMOLEON THERAPEUTICS LTD is 71-75 Shelton Street, Covent Garden, London, United Kingdom, WC2H 9JQ. This is the official address filed with Companies House for legal and statutory correspondence.
Is TIMOLEON THERAPEUTICS LTD financially stable?
Financial accounts for TIMOLEON THERAPEUTICS LTD are not currently available. Without filed accounts, it is more difficult to assess the company's financial stability and trading performance.